Reduced-Intensity Stem Cell Transplantation for Hematological Malignancies: Current Status and the Future
Journal:
Current Stem Cell Research & Therapy
Volume:
2
Page:
149-162
Author(s):
Koji Kato, Yasser Khaled and Shin Mineishi
Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Journal:
Reviews on Recent Clinical Trials
Volume:
2
Page:
103-110
Author(s):
Sonali M. Smith
Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
Journal:
Reviews on Recent Clinical Trials
Volume:
2
Page:
135-141
Author(s):
Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke and Lucy A. Godley
New Treatment Concepts In Diffuse Large B-Cell Lymphomas (DLBL): Chemotherapy and Biological Therapy
Journal:
Reviews on Recent Clinical Trials
Volume:
2
Page:
149-162
Author(s):
Jose Rodriguez and Antonio Gutierrez
The Cancer Related Thrombotic Tendency in Sepsis
Journal:
Current Drug Targets
Volume:
8
Page:
543-549
Author(s):
David E. Joyce
Drug Resistance and Methylation in Myelodysplastic Syndrome
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
77-81
Author(s):
D. O. Vidal, L. F. Lopes and E. T. Valera
mTOR Inhibition in Lymphoma: A Rational and Promising Strategy
Journal:
Letters in Drug Design & Discovery
Volume:
4
Page:
224-231
Author(s):
Sonali M. Smith and Koen van Besien
Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
689-701
Author(s):
Junkang Xu, Hui Peng and Jian Ting Zhang
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
671-686
Author(s):
Antonino Belfiore
Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
687-703
Author(s):
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon